GFAP and astrocytoma (excluding glioblastoma): Since wild-type EGFR and mutant EGFRvIII are the most common gain-of-function alterations in malignant human astrocytomas, they reported the generation of mice expressing these proteins under the regulation of the GFAP promoter [10, 11].